Azenta, Inc. (AZTA) fair value analysis

Nasdaq · Updated 2026-09-07

Azenta, Inc. is a healthcare company that provides sample management and storage solutions, including cryogenic freezers and biorepository services, primarily serving life sciences research, clinical diagnostics, and pharmaceutical development organizations. The company operates globally with facilities and customers across North America, Europe, and Asia-Pacific regions.

Forward Fair Value verdict

Fairly valued

Based on TickrTrends' weekly Forward Fair Value model, AZTA is trading at within about 10% of estimated fair value.

AZTA currently ranks #72 of 113 Healthcare stocks by discount to Forward Fair Value. It has screened as Fairly valued for 3 consecutive weekly runs.

Last price: $29.88
Sector: Healthcare
12-month range: $21.18–$37.53

Derived indicators

Coarse bands from TickrTrends' weekly models; exact figures are part of the full report.

Quality grade: D
Leverage: Low
RSI zone: Neutral
50/200-day trend: Uptrend
52-week position: The upper-middle quarter of its range

What our data shows for AZTA

Our model validated 8 trailing price-to-earnings windows for AZTA, built from quarterly earnings records.
Shares are trading in the middle of their 12-month price range of $21.18–$37.53.
The 14-day relative strength index sits at a neutral 46.

The exact numbers are one step away

The precise Forward Fair Value dollar figure for AZTA
Exact discount / premium to today's price
The normalized historical P/E behind the estimate, and how many quarters support it
Forward EPS input and fiscal-year basis
Screeners and rankings across the full S&P 500 and Nasdaq universes

See the exact fair value →

How Forward Fair Value works

TickrTrends computes a Forward Fair Value for every covered stock each week: a conservatively normalized historical price-to-earnings multiple is applied to the analyst-consensus earnings estimate for the next full fiscal year. Every input window is validated for continuity and every result is screened for plausibility before publication.

What people are saying

Follow the AZTA conversation: Stocktwits · Reddit · X

TickrTrends weekly updates

2026-09-07 — No material change this week: the verdict, bands and grades all held steady.
2026-09-06 — No material change this week: the verdict, bands and grades all held steady.
2026-08-31 — TickrTrends initiated weekly Forward Fair Value coverage of this stock.

Frequently asked questions

Is AZTA stock undervalued?

Based on TickrTrends' Forward Fair Value model (updated 2026-09-07), AZTA is trading at within about 10% of estimated fair value and screens as fairly valued. The exact fair value and discount are available to subscribers.

What is AZTA's TickrTrends verdict?

AZTA's current verdict is Fairly valued, refreshed with every weekly Forward Fair Value run.

How does AZTA compare to other Healthcare stocks?

AZTA ranks #72 of 113 Healthcare stocks in TickrTrends' coverage when sorted by discount to Forward Fair Value.

Is AZTA overbought or oversold?

AZTA's 14-day RSI is in neutral territory - neither overbought nor oversold.

All Healthcare fair-value coverage →

Head-to-head comparisons

AZTA vs ACHC · AZTA vs COR · AZTA vs ELV · AZTA vs HSIC · AZTA vs IQV